龍藉泉醫師發表論文與書籍

1. Loong CC, Huang MH, Chien KY. Perforation and rupture of the esophagus – ten years of experience. J Surg Assoc R.O.C 1987; 20:193-201.

2. 龍藉泉：腎臟移植－外科方面的一些問題，腎臟與透析。1991; 3:168-172.

3. Jwo SC, Chiu YH, Chau GY, Loong CC, Lui WY. Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology 1992; 16:1367-1371. (SCI)

4. Chiu YH, Wu LH, Kao HL, Chang HM, Tsay SH, Loong CC, Chau GY, Lui WY. Can determination of the proliferative capacity of the nontumor portion predict the risk of tumor recurrence in the liver remnant after resection of human hepatocellular carcinoma? Hepatology 1993; 18:96-102. (SCI)

5. Lu SH, Chiu AW, Loong CC, Wu LH, Chen MT, Chang LS. Flow cytometric deoxyribonucleic acid analysis of bilateral renal cell carcinoma. J Urol R.O.C 1993; 4:1235-1239.

6. Lin CY, Chen WP, King KL, Loong CC. Pediatric renal transplantation in Veterans General Hospital - Taipei, Taiwan. Transplant Proc 1994; 26:57-59. (SCI)

7. Sun LW, Loong CC, Chiu JH, Chau GY, Jwo SC, Lui WY. Definitive surgery for perforated peptic ulcer in the elderly. J Surg Assoc R.O.C 1994; 27:2351-2358.

8. Lee SF, Yang WC, Loong CC, King KL, Lin MF. Individualization of cylcosporine therapy in renal transplantation. Transplant Proc 1994; 26:1917-1919. (SCI)

9. Chang YT, Loong CC, Wang HC, Jwo SC, Lui WY. Breast cancer and pregnancy. Chin Med J (Taipei ) 1994; 54:223-229.

10. Lui WY, Chau GY, Loong CC, Tsay SH, Wu JC, King KL, Chiu JH, Lai CR, P'eng FK. Hepatic segmentectomy for curative resection of primary hepatocellular carcinoma. Arch Surg 1995; 130:1090-1097. (SCI)

11. Su CH, Shyr YM, Loong CC, Yu TJ, Wu JK, Liu M, Lee CH, Lui WY. The use of octreotide in the treatment of pancreatic cutaneous fistula. J Surg Assoc R.O.C 1995; 28:468-476.

12. Loong CC, Chen A, Lui WY, King KL, Lin CY. Expression of Cytokines, Growth Factors, and Adhesion Molecules in Rejecting Human Renal Allograft. Transplant Proc 1996; 28:1445-1446. (SCI)

13. Tung WY, Chau GY, Loong CC, Wu JC, Tsay SH, King KL, Huang SM, Chiu JH, Wu CW, Lui WY. Surgical resection of primary hepatocellular carcinoma extending to adjacent organ(s). Eur J Surg Oncol 1996; 22:516-520. (SCI)

14. Shen KH, Loong CC, Chau GY, Chiu JH, Wu CW, Lui WY. Factors related to mortality in patients with mesenteric infarction. J Surg Assoc R.O.C 1996; 29:391-395.

15. Chiu ST, Chiu JH, Lui WY, Chau GY, Loong CC, Wu CW. Prognostic factors affecting long-term survival after partial hepatectomy for human hepatocellular carcinoma. Chin Med J (Taipei ) 1997; 59:177-185.

16. Yu SY, Chiu JH, Loong CC, Wu CW, Lui WY. Diagnostic laparoscopy: indication and benefit. Chin Med J (Taipei ) 1997; 59:158-163.

17. Sun DP, Loong CC, Chiu JH, Lui WY, Wu CW. Clinical consequence of adenocarcinoma in the jejunum and ileum. J Surg Assoc R.O.C 1997; 30:162-168.

18. Ou LH, Chau GY, Tsay SH, Chiu JH, Wu JC, King KL, Loong CC, Wu CW, Lui WY. Clinicopathological comparison of resectable hepatocellular carcinoma between the young and the elderly patients. Chin Med J (Taipei ) 1997; 60:40-47.

19. Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Chiu JH, Wu CW, P’eng FK. Prognostic significance of surgical margin in hepatocellular carcinoma resection: an analysis of 165 Child’s A patients. J Surg Onco 1997; 66:122-126. (SCI)

20. Chiu JH, Lui WY, Chang HM, Loong CC, Wu LH, Kao HL, Wu CW. Class I and Class II major histocompatibility complex antigens expression on human hepatocytes and hepatoma cells: an approach with high sensitivity and specificity. Cytometry 1997; 30:317-323. (SCI)

21. 龍藉泉：移植醫學未來之趨勢，臨床醫學。1998; 42:55-58.

22. Lui WY, Chiu ST, Chiu JH, Loong CC, Chau GY, King KL, Hsia CY, Wu CW, P'eng FK. Evaluation of a simplified staging system for prognosis of hepatocellular carcinoma. J Formosa Med Assoc 1999 Apr; 98(4):248-253. (SCI)

23. 龍藉泉：小腸移植，臨床醫學。1999; 44:266-271.

24. 龍藉泉：復發性鼠蹊部疝氣，臨床醫學。1999; 44:412-413.

25. Chenhsu RY, Loong CC, Chou MH, Lin MF, Yang WC. Renal allograft dysfunction associated with rifampin-tacrolimus interaction. Ann Pharmacother 2000 Jan; 34(1):27-31. (SCI)

26. Huo TY, Yang WC, Wu JC, King KL, Loong CC, Lin CY, Lui WY. Impact of hepatitis B and C virus infection on the outcome of kidney transplantation in Chinese patients. Chin Med J (Taipei) 2000; 63:93-100.

27. Chen JH, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Hsia JY, Wu CW. Surgical results in patients with Hepatitis B related hepatocellular carcinoma and positive hepatitis B early antigen. World J Surg 2000 Mar; 24(3):383-388. (SCI)

28. Chau GY, Wu CW, Lui WY, Chang TJ, Kao HL, Wu KH, King KL, Loong CC, Hsia CY, Chi CW. Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma. Ann Surg 2000 Apr; 231(4):552-558. (SCI)

29. Tsai TJ, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Hsia CY, Wu CW. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 2000 Jun; 127(6): 603-608. (SCI)

30. Hsia CY, Lui WY, Chau GY, King KL, Loong CC, Wu CW. Perioperative safety and prognosis in hepatocellular carcinoma patients with impaired liver function. J Am Coll Surg 2000 May; 190(5):574-579. (SCI)

31. Fan YG, Chiu JH, Chau GY, Loong CC, Lee RC, Tsay SH, Wu CC, Lui WY. Clinical manifestation of hepatic hemangioma undergoing partial liver resection. Formosan J Surg 2000; 33:59-65.

32. Lee CC, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Hsia CY, Wu CW. Better post-resectional survival in female cirrhotic patients with hepatocellular carcinoma. Hepato-Gastroenterol 2000 Mar-Apr; 47(32):446-449. (SCI)

33. Yang WC, Chen YF, King KL, Wu TH, Chen Hsu RY, Tang JJ, Loong CC, Chou MH, Lin MF, Lui WY. Optimization of cyclosporine therapy with abbreviated area under the curve method in renal transplant. Transplant Proc 2000 Nov; 32(7): 1685-1687. (SCI)

34. Loong CC, Lin CY, Lui WY. Expression of interleukin-17 as a predictive parameter in acute renal allograft rejection. Transplant Proc 2000 Nov; 32(7): 1773. (SCI)

35. Huo TI, Yang WC, Wu JC, King KL, Lin CY, Loong CC, Lui WY, Chang FY, Lee SD. Long-term outcome of kidney transplantation in patients with hepatitis C virus infection. Hepato-Gastroenterol 2001 Jan-Feb; 48(37):169-173. (SCI)

36. Huo TI, Yang WC, Wu JC, King KL, Loong CC, Lin CY, Chang FY, Lee SD. Kidney transplantation in patients with chronic hepatitis B virus infection-is the prognosis worse? Dig Dis Sci 2001 Mar; 46(3):469-475. (SCI)

37. Chen TH, Tseng LM, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Hsia CY, Wu CW. Clinicopathologic and prognostic differences between patients with Hepatitis B- and C-related respectable hepatocellular carcinoma. J Formos Med Assoc 2001 Jul; 100(7):443-448. (SCI)

38. Hsieh HG, Loong CC, Lui WY, Chen A, Lin CY. IL-17 expression as a possible predictive parameter for subclinical renal allograft rejection. Transplant Int 2001 Sep; 14(5):287-298. (SCI)

39. Loong CC, Chiu JH, Tiao RC, Chiu YY, Wu CW, Lui WY. Pretreatment with magnolol attenuates ischemia-reperfusion injury in rat small intestine. Transplant Proc 2001Nov-Dec; 33(7-8):3737-3738. (SCI)

40. Loong CC, Hsieh HG, Lui WY, Chen A, Lin CY. Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J Pathol 2002 Jul; 197(3):322-332. (SCI)

41. Hsieh HG, Loong CC, Lin CY. Interleukin-17 induces src/MAPK cascades activation in human renal epithelial cells. Cytokine 2002Aug; 19(4):159-174. (SCI)

42. Loong CC, Chiu JH, Tiao RC, Chiu YY, Wu CW, Lui WY. Protective effect of magnolol on the small intestinal ischemia-reperfusion injury. Transplant Proc 2002 Nov; 34(7):2679-2680. (SCI)

43. Hsia CY, Chau GY, King KL, Loong CC, Lui WY, Wu CW. Factors for prolonged length of stay after elective hepatectomy for hepatocellular carcinoma. The surgeon’s role in the managed care era. Hepato-gastroenterology 2003 May-Jun; 50(51):798-804. (SCI)

44. Kwok CM, Lui WY, King KL, Loong CC, Chau GY, Kwang WK, Hsia CY, Wu CW. Intrahepatic splenosis: report of a case. Formos J Surg 2003; 36:301-305.

45. Huo TI, Wu JC, Lui WY, Lee RC, Loong CC, Huang YH, Tsay SH, Chang FY. Reliability of contemporary radiology to measure tumour size of hepatocellular carcinoma in patients undergoing resection: limitations and clinical implications. Scand J Gastroenterol 2004 Jan; 39(1):46-52. (SCI)

46. Huo TI, Lui WY, Wu JC, Huang YH, King KL, Loong CC, Lee PC, Chang FY, Lee SD. Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor recurrence. World J Surg 2004 Mar; 28(3):258-262. (SCI)

47. Chen WT, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Wu CW. Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome. Euro J Surg Onco 2004 May; 30(4):414-420. (SCI)

48. Loong CC, Wu CW, Lui WY. Antioxidant supplementation may improve renal transplant function. Transplant Proc 2004 Oct; 36(8):2438-2439. (SCI)

49. Hsu CW, Lui WY, Chau GY, King KL, Loong CC, Hsia CY, Lee RC, Li AFY, Wu CW. Clinical characteristics of patients undergoing surgical resection of benign liver tumors in Taiwan, an endemic area for hepatocellular carcinoma. J Formos Med Assoc 2004 Nov; 103(11):824-829. (SCI)

50. Lee CC, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Hsia CY, Wu CW. Risk factors associated with bile leakage.after hepatic resection for hepatocellular carcinoma. Hepato-gastroenterology 2005 Jul-Aug; 52(64):1168-71. (SCI)

51. Lai HW, Loong CC, Wu CW, Lui WY. Watchful waiting versus interval appendectomy for patients who recovered from acute appendicitis with tumor formation: A cost-effectiveness analysis. J Chin Med Assoc 2005; 68:431-434.

52. Lai HW, Loong CC*, Chiu JH, Chau GY, Wu CW, Lui WY. Interval appendectomy after conservative treatment of an appendiceal mass. World J Surg 2006 Mar; 30(3):351-357. (SCI)

53. Liu C, Tsai HL, Loong CC, Hsia CY, Chin T, Wei C. ENDO-GIA Staplers for Side-to-Side Anastomosis of Veins. Eur J Vasc Endovasc Surg. 2006 Nov; 32(5): 584-8. (SCI)

54. Lai HW, Loong CC*, Tai LC, Wu CW, Lui WY. Incidence and odds ratio of appendicitis as first manifestation of colon cancer: A retrospective analysis of 1873 patients. J Gastro Hepatolo 2006 Nov; 21(11): 1693-6. (SCI)

55. Lei HJ, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Wu CW. Prognostic value and clinical relevance of the 6th edition 2002 American joint committee on cancer staging system in patients with respectable hepatocellular carcinoma. J Am Coll Surg 2006 Oct; 203(4): 426-35. (SCI)

56. Fan WC, King KL, Loong CC, Wu CW. Hepatocellular carcinoma after renal transplantation: the long-term impact of cirrhosis on chronic hepatitis B virus infection. Transplant Proc. 2006 Sep; 38(7): 2080-3. (SCI)

57. Liu C, Tsai HL, Chin T, Loong CC, Hsia CY, Wei C. Clamping the supra-celiac aorta can effectively increase the success rate of orthotopic rat liver transplantation by increasing the tolerable time of the anhepatic phase. J Surg Res. 2006 Nov; 136(1):116-9. (SCI)

58. Liu C, Loong CC, Hsia CY, Tsai HL, Wei CF. Modified side-to-side cavocaval anastomosis in selected cases of orthotopic liver transplantation. Surgery. 2007 Jul; 142(1): 123-4 (SCI)

59. Lin NC, Hsia CY, Loong CC, Liu CS, Tsai HL, Lui WY, Wu CW. Liver transplantation at a small-volume procedure center---preliminary results from Taipei Veterans General Hospital. J Chin Med Assoc.: JCMA. 2008 Apr; 71(4): 186-90. (SCI)

60. Liu C, Loong CC, Hsia CY, Tsou MY, Tsai HL, Wei CF. Venoplasty of hepatic venous outflow with a venous patch in domino liver transplantation. Liver Transplant. 2008 Sep; 14(9):1378-9. (SCI)

61. Wei HK, Loong CC*, King KL, Wu CW, Lui WY. HBsAg(+) donor as a kidney transplantation deceased donor. Transpl P. 2008 Sep; 40(7):2097-9. (SCI)

62. Wang HK, Chou YH, Yang AH, Chiou SY, Chiou HJ, Wu TH, Loong CC, Chang CY. Evaluation of cortical perfusion in renal transplants: application of quantified power Doppler ultrasonography. Transpl P. 2008 Sep; 40(7):2330-2. (SCI)

63. Yang MH, Loong CC*, Wu CW, Lui WY. Late spontaneous kidney graft decapsulation after administration of sirolimus in a recipient with chronic hepatitis B and C infection: a case report. Transpl P. 2008 Sep; 40(7):2437-9. (SCI)

64. 李苑甄、廖麗鳳、吳蘊華、龍藉泉、周月卿．器官移植病人發生移植後糖尿病之研究分析．醫院藥學．2008; 25: 91-5．

65. 李苑甄、龍藉泉、周月卿．腎臟移植後伺機感染肺結核之用藥探討．醫院藥學．2008; 25: 139-43

66. Liu C, Hsia CY, Loong CC, Perng CK, Huang CH, Tsai HL, Tsou MY, Wei C. A technique of diamond-shape venoplasty to reconstruct the hepatic venous outflow in living donor liver transplantation for a case of Budd-Chiari syndrome. Pediatr Transplant. 2009 Feb; 13(1):35-8. (SCI)

67. Yang YY, Huang YT, Lin HC, Lee FY, Lee KC, Chau GY, Loong CC, Lai CR, Lee SD. Thalidomide decreases intrahepatic resistance in cirrhotic rats. Biochim. Biophys. Res. Com. 2009 Mar. 380(3):666-72. (SCI)

68. Yang YY, Lee KC, Huang YT, Lee FY, Chau GY, Loong CC, Lin HC, Lee SD. Inhibition of hepatic tumour necrosis factor-α attenuates the anandamide-induced vasoconstrictive response in cirrhotic rat livers. Liver Int. 2009 May; 29(5):678-85. (SCI)

69. Huo TI, Huang YH, Hsia CY, Su CW, Lin HC, Hsu CY, Lee PC, Lui WY, Loong CC, Chiang JH, Chiou YY, Lee SD. Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection? Liver Int. 2009 May; 29(5):767-73. (SCI)

70. Hung HH, Chen TS, Tseng HS, Hsia CY, Liu CS, Lin HC, Loong CC. Percutaneous transhepatic cholangiography and drainage is an effective rescue therapy for biliary complications in liver transplant recipients who fail endoscopic retrograde cholangiopancreatography. J Chin Med Assoc. 2009 Aug; 72(8):395-401.

71. Huo TI, Hsia CY, Huang YH, Lin HC, Lee PC, Lui WY, Chiang JH, Chiou YY, Loong CC, Lee SD. Selecting a Short-term Prognostic Model for Hepatocellular Carcinoma: Comparison Between the Model for End-stage Liver Disease (MELD), MELD-sodium, and Five Cancer Staging Systems. J Clin Gastroenterol. 2009 Sep; 43(8):773-81. (SCI)

72. Liu C, Loong CC, Hsia CY, Peng CK, Tsai HL, Tsou MY, Wei C. Duct-to-duct biliary reconstruction in selected cases in pediatric living-donor left-lobe liver transplantation. Pediatr Transplant. 2009 Sep;13(6):693-6.(SCI)

73. Kuo WT, Hsia CY, Loong CC, Liu CS, Tsai HL, Tseng HS, Lee RC, Tsou MY, Wu CW, Lui WY. Outcome of foreign residents undergoing deceased donor liver transplantation in China: a single center experience in Taiwan. Liver Transplant 2009 Nov; 15(11): 1579-85. (SCI)

74. Liu C, Loong CC, Hsia CY, Tsai HL, Wei CF. ENDO-GIA staplers for side-to-side anastomosis of veins. Liver Transpl. 2009 Nov; 15(11):1655. (SCI)

75. Liu C, Loong CC, Hsia CY, Tsou MY, Tsai HL, Wei C. Retrograde arterial flush of the liver graft in living donor liver transplantation. J Invest Surg. 2009 Nov-Dec; 22(6): 406-12. (SCI)

76. Huo TI, Hsu CY, Huang YH, Hsia CY, Lin HC, Lee PC, Loong CC, Chiang JH, Chiou YY, Lee SD. Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinoma. Liver Int. 2010 Feb; 30(2): 198-207. (SCI)

77. Lin NC, Liu CS, Chang CJ, Loong CC, Hsia CY, Tsai HL. Changes in mitochondrial respiratory enzyme activity after ischemia-reperfusion injury in living-donor liver transplantation. Transplant Proc. 2010 Apr; 42(3): 721-4. (SCI)

78. 王世仁，劉宗榮，龍藉泉．從國外的經驗來看我國移植用組織庫的發展．醫院．2010 Apr; 43(2): 13-20.

79. 吳天予，王世仁，劉宗榮，龍藉泉．移植用組織庫的稽查．醫院．2010 Apr; 43(2): 42-54.

80. Liu CS, Niu DM, Loong CC, Hsia CY, Tsou MY, Tsai HL, Wei CF. Domino liver graft form a patient with homozygous familial hypercholesterolemia. Pediatr Transplant. 2010 May; 14(3): E30-33. (SCI)

81. Hsu CY, Huang YH, Hsia CY, Su CW, Lin HC, Loong CC, Chiou YY, Chiang JH, Lee PC, Huo TI, Lee SD. A new prognostic model for hepatocellular carcinoma based on total tumor volume: The Taipei Integrated Scoring system. J Hepatol. 2010 Jul; 53(1):108-17. (SCI)

82. Lee KC, Yang YY, Wang YW, Lee FY, Loong CC, Hou MC, Lin HC, Lee SD. Increased plasma malondialdehyde in patients with viral cirrhosis and its relationships to plasma nitric oxide, endotoxin, and portal pressure. Dig Dis Sci. 2010 Jul; 55(7):2077-85.

83. Hsu CY, Hsia CY, Huang YH, Su CW, Lin HC, Lee PC, Loong CC, Chiang JH, Huo TI, Lee SD. Selecting an optimal staging system for hepatocellular carcinoma: comparison of 5 currently used prognostic models. Cancer. 2010 Jun; 116(12):3006-14.

84. Liu C, Lee RC, Loong CC, Hsia CY, Yeh YC, Chiou SY. Increasing Donor Body Weight to Prevent Small-for-Size Syndrome in Living Donor Liver Transplantation. World J Surg. 2010 Oct; 34(10):2401-8. (SCI)

85. Lin NC, Yang AH, King KL, Wu TH, Yang WC, Loong CC*. Results of kidney transplantation from high-terminal creatinine donors and the role of time-zero biopsy. Transpl Proc. 2010 Nov; 42(9):3382-6. (SCI)

86. Wang SC, Shieh JF, Chang KY, Chu YC, Liu CS, Loong CC, Chan KH, Mandell S, Tsou MY. Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial. Transplant Proc. 2010 Sep; 42(7):2590-3. (SCI)

87. Tsao SY, Lee WC, Loong CC, Chen TJ, Chiu JH, Tai LC. High-surgical-volume hospitals associated with better quality and lower cost of kidney transplantation in Taiwan. J Chin Med Assoc. 2011 Jan; 74(1): 22-7.

88. Chen LH, Loong CC, Su TL, Lee YJ, Chu PM, Tsai ML, Tsai PH, Tu PH, Chi CW, Lee HC, Chiou SH. Autophagy inhibition enhances apoptosis triggered by BO-1051, an N-mustard derivative, and involves the ATM signaling pathway. Biochem Pharmacol. 2011 Mar; 81(5):594-605. (SCI)

89. Tan TJ, Chen CL, Lee WC, Loong CC, Lee PH, Yong CC, Chou HS, Hsia CY, Liu CS, Hu RH. Tacrolimus Once-Daily (Advagrat) Versus Twice-Daily (Prograf) in De Novo Liver Transplantation; a Multi-Center Randomized Phase III Study Comparing Safety and Efficacy. Liver Transplant 2011 Jun; 17(6): S263-S263. (SCI)

90. Liu CS, Niu DM, Hsia CY, Loong CC, Lin NC. Liver transplantation for a case of homocystinuria. Pediatr Transplant 2011 Aug; 15(s1): The 6th Congress of the International Pediatric Transplant Association Abstracts #327

91. Liu C, Lee RC, Loong CC, Hsia CY. "Consideration not Promotion": In Selected Cases, We Can Try to Increase Donor Body Weight to Increase Graft Volume in Living Donor Liver Transplantation: Reply. World J Surg. 2011 Oct; 35(10):2358-9. (SCI)

92. Wang HK, Chiou SY, Lai YC, Cheng HY, Lin NC, Loong CC, Chiou HJ, Chou YH, Chang CY. Early postoperative spectral Doppler parameters of renal transplants: the effect of donor and recipient factors. Transplant Proc. 2012 Jan; 44(1):226-9. (SCI)

93. Chang WT, Lin NC, Hsia CY, Liu CS, Tsai HL, Loong CC*. Liver Transplantation for a renal transplantation recipient with secondary sclerosing cholangitis by choledochoduodenal fistula. Asian J Surg. 2012 Jan; 35(1):49-52. (SCI)

94. Liu C, Niu DM, Hsia CY, Loong CC, Lin NC, Tsai HL, Tsou MY, Chin T. Living donor liver transplantation using a graft from a donor with Dubin-Johnson syndrome. Pediatr Transplant. 2012 Feb; 16(1):E25-9. (SCI)

95. Hsu CY, Hsia CY, Huang YH, Su CW, Lin HC, Pai JT, Loong CC, Chiou YY, Lee RC, Lee FY, Huo TI, Lee SD. Comparison of Surgical Resection and Transarterial Chemoembolization for Hepatocellular Carcinoma beyond the Milan Criteria: A Propensity Score Analysis. Ann Surg Oncol. 2012 Mar; 19(3):842-9. (SCI)

96. Liu C, Loong CC, Hsia CY, Wang SC, Yeh YC, Lin NC, Tsai HL, Tsou MY. Retrograde arterial flush of the liver graft in living donor liver transplantation may ameliorate post-transplantational cholestasis - a prospective randomized study. Clin Transplant. 2012 Mar-Apr; 26(2):305-13. (SCI)

97. Tian YF, Tsai CS, Lee PC, Chu SH, Chien YS, Loong CC, Chen CH, Wu MS, Chu SH, Lian JD. New-Onset Diabetes Mellitus in Cyclosporine-Treated Organ Transplant Patients in Taiwan: Interim Analysis (6 Months) of Postmarketing Surveillance. Transplant. Proc. 2012 Apr; 44(3): 661-6. (SCI)

98. Wang HK, Lai YC, Tseng HS, Lee RC, Loong CC, Lin NC, Chou YH, Chiou HJ, Chang CY. Hepatic venous congestion after living donor liver transplantation: quantitative assessment of liver stiffness using shear wave elastography--a case report. Transplant Proc. 2012 Apr; 44(3):814-6. (SCI)

99. Chen CY, Wang JB, Lin NC, Lee JT, Tsai HL, Chin T, Loong CC, Hsia CY, Liu C. Three liver grafts from a deceased whole liver. Med Hypotheses. 2012 May; 78(5):668-71. (SCI)

100. Wang SC, Lin HT, Chang KY, Mandell S, Ting CK, Chu YC, Loong CC, Chan KH, Tsou MY. The use of higher thromboelastogram transfusion values is not associated with greater blood loss in liver transplant surgery. Liver Transpl. 2012 Oct; 18(10): 1253-7. (SCI)

101. Lee YH, Hsu CY, Hsia CY, Huang YH, Su CW, Lin HC, Loong CC, Chiou YY, Huo TI. Defining the severity of liver dysfunction in patients with hepatocellular carcinoma by the model for end-stage liver disease-derived systems. Dig Liver Dis. 2012 Oct; 44(10):868-74. (SCI)

102. Lin NC, Niu DM, Loong CC, Hsia CY, Tsai HL, Yeh YC, Tsou MY, Liu CS. Liver transplantation for a patient with homocystinuria. Pediatr Transplant. 2012 Nov; 16(7):E311-4. (SCI)

103. Wang SC, Teng WN, Chang KY, Susan Mandell M, Ting CK, Chu YC, Loong CC, Chan KH, Tsou MY. Fluid management guided by stroke volume variation failed to decrease the incidence of acute kidney injury, 30-day mortality, and 1-year survival in living donor liver transplant recipients. J Chin Med Assoc. 2012 Dec; 75(12):654-9. (SCI)

104. Wu YS, Lin NC, Chen IM, Chang SC, Wang FD, Huang YC, Wu TH, Loong CC*. Extracorporeal membrane oxygenation as treatment for acute respiratory failure and subsequent pneumothorax caused by Pneumocystis jirovecii pneumonia in a kidney transplant recipient. Transpl Infect Dis. 2013 Feb; 15(1):E5-8. (SCI)

105. Scholbach T, Wang HK, Yang AH, Loong CC, Wu TH. Correlation of histopathologic and dynamic tissue perfusion measurement findings in transplanted kidneys. BMC Nephrology 2013 Jul, 14:143. (SCI)

106. Perrillo R, Buti M, Durand F, Charlton M, Gadano A, Cantisani G, Loong CC, Brown K, Hu W, Lopez-Talavera JC, Llamoso C. Entecavir and HBIg in patients receiving liver transplant for chronic hepatitis B. Liver Transpl. 2013 Aug; 19(8):887-95. (SCI)

107. Chen CY, Tseng HS, Lin NC, Wang JB, Tsai HL, Loong CC*, Hsia CY, Liu C. A bidirectional approach for portal vein stent placement in a child with complete portal vein occlusion after living donor liver transplantation. Pediatr Transplant. 2013 Sep; 17(6):E137-40. (SCI)

108. Tsai HL, Chang JW, Wu TH, King KL, Yang LY, Chan YJ, Yang AH, Chang FP, Pan CC, Yang WC, Loong CC*. Outcomes of Kidney Transplant Tourism and Risk Factors for De Novo Urothelial Carcinoma. Transplantation. 2014 Jul; 98(1):79-87. (SCI)

109. Chen CY, Liu CJ, Feng JY, Loong CC, Liu C, Hsia CY, Hu LY, Lin NC, Hu YW, Yeh CM, Chen TJ, Yang CC. Incidence and risk factors for tuberculosis after liver transplantation in an Endemic Area: A nationwide population-based matched cohort study. Am J Transplant. 2015 Aug; 15(8):2180-7.

110.Lin NC, Wang HK, Yeh YC, Liu CP, Loong CC, Tsai HL, Chen CY, Chin T, Liu C. Minimization or withdrawal of immunosuppressants in pediatric liver transplant recipients. J Pediatr Surg. 2015 Dec; 50(12):2128-33.

111.Chen TW, Chen CY, Lin NC, King KL, Wu TH, Yang WC, Loong CC. How to Improve the Positive Predictive Value of Urinary Decoy Cell Surveillance for Polyomavirus BK-Associated Nephropathy in Kidney Transplant Patients. Transplant Proc. 2016 Apr; 48(3):924-8.

112.Huang YY, Hsu CC, Chou CL, Loong CC, Wu MS, Chou YC. Trends in the use of maintenance immunosuppressive drugs among liver transplant recipients in Taiwan: a nationwide population-based study. Pharmacoepidem Drug Saf. 2016 Jun; 25(6):661-7.

113.Chen CY, Liu CS, Lin NC, Tsai HL, Loong CC, Hsia CY. Exchange of Partial Liver Transplantation Between Children with Different Non-Cirrhotic Metabolic Liver Diseases: How Do We Arrive There? Ann Transpl. 2016 Aug; 21:525-530.

114.Wu TH, Lee HT, Lai CC, Yang AH, Loong CC, Wang HK, Yu CL, Tsai CY. Suppressor of cytokine signaling (SOCS) 1 is down-regulated in renal transplant recipients with rejection. Transpl Immunol. 2016 Sep; 38:54-9.

115.Hsia K, Yang MJ, Chen WM, Yoa CL, Lin CH, Loong CC, Huang YL, Lin YT, Lander AD, Lee H, Lu JH. Sphingosine-1-phosphate improves endothelialization with reduction of thrombosis in recellularized human umbilical vein graft by inhibiting syndecan-1 shedding in vitro. Acta Biomater. 2017 Mar; 51: 341-50.

116.Yang AH, Loong CC, Lin NC, Yang CY. Isolated Crystalloid Podocytopathy With Focal Segmental Glomerulosclerosis in Renal Allograft: An Unusual Presentation of Post-Transplant Monoclonal Gammopathy of Renal Significance-A Case Report. Transplant Proc. 2017 Dec; 49(10):2299-2301.

117.Wang HK, Chen CY, Lin NC, Liu CS, Loong CC, Lin YH, Lai YC, Chiou HJ. Comparison of Two Devices for Intraoperative Portal Venous Flow Measurement in Living-Donor Liver Transplantation: Transit Time Ultrasound and Conventional Doppler Ultrasound. Transplant Proc. 2018 May; 50(4):1157-1159.

118.Chung MH, Chuang CC, Liaw LF, Chen CY, Chen IM, Hsu CP, Lin NC, Loong CC*. Thrombotic Ringed Polytetrafluoroethylene Graft With Infection After Living-Donor Liver Transplantation. Transplant Proc. 2018 Nov; 50(9): 2606-10.